BOdygUardian MOnitoriNg for ReCurrencE of AF
Part of paid clinical trials in Delray Beach, Florida.
- Sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Study ID
- NCT07671677
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Atrial Fibrillation (AF)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- BodyGuardian — DEVICEBodyGuardian wear at 6 months
Study Details
The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the FARAPULSE Pulsed Field Ablation (PFA) System for the treatment of atrial fibrillation (AF). The data collected for this study will be from a subset of patients enrolled in the pre-existing DISRUPT AF Registry. Additionally, patients in the Full Monitoring Arm may be approached and consented for participation in BOUNCE-AF. The post-ablation monitoring timepoints will reflect the site's standard of care (SOC), which is typically at 6- and 12-months post-ablation. Consented patients will complete 1 survey about their experience after wearing the BodyGuardian at 6-months. Clinical staff that consent will also complete a survey on their experience using BodyGuardian. The clinical staff include those that either directly prescribe the monitor, place the monitor on the patient and/or train the patient on the use of the monitor, or those involved in reviewing the data.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Primary Objectives [ Time Frame: From enrollment to the end of BodyGuardian wear at 6 months ]
Central Contacts
- Kayla Oliver763-381-7972
- Megan Goodfellow563-599-4146
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arrhythmia Center of South Florida | Delray Beach | Florida | 33484 | - |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | - |
| St. Mark's Hospital | Salt Lake City | Utah | 84124 | - |
Find similar trials in Delray Beach, FL
Related Studies
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)PHASE3 · Recruiting · Anthos Therapeutics, Inc. · Birmingham, Alabama
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling By Invitation · Peerbridge Health, Inc · Melbourne, Florida
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationRecruiting · Arga Medtech SA · Birmingham, Alabama
- Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)Recruiting · McMaster University · Evanston, Illinois